InflaRx IFRX is gearing up to announce its quarterly earnings on Friday, 2024-11-08. Here's a quick overview of what investors should know before the release.
Analysts are estimating that InflaRx will report an earnings per share (EPS) of $-0.28.
InflaRx bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Earnings History Snapshot
Last quarter the company missed EPS by $0.05, which was followed by a 2.99% increase in the share price the next day.
Here's a look at InflaRx's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.21 | -0.24 | -0.2 | -0.25 |
| EPS Actual | -0.26 | -0.18 | -0.3 | -0.14 |
| Price Change % | 3.0% | 0.0% | -3.0% | -14.000000000000002% |
Stock Performance
Shares of InflaRx were trading at $1.53 as of November 06. Over the last 52-week period, shares are up 17.97%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.
To track all earnings releases for InflaRx visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
